Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

29

Revenue 2017

Soliris

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Soliris was produced by Alexion.

Medimmune-born Viela files $150m IPO, eyes first product launch

Medimmune-born Viela files $150m IPO, eyes first product launch NMOSD patients have few treatment options, although Alexion’s blockbuster complement C5 inhibitor  Soliris(eculizumab) recently became the first drug to be FDA-approved for this indication.

Amgen takes aim at Alexion’s patents for Soliris

Amgen takes aim at Alexion’s patents for Soliris Now, it’s filed a patent infringement action against Alexion’s top-selling drug Soliris. ... In trials, Ultomiris matched Soliris for efficacy – with a trend towards superiority – and offers improved dosing.

AstraZeneca buys FDA priority review voucher from Sobi

AstraZeneca buys FDA priority review voucher from Sobi Last June, Alexion used its own PRV for its rare blood disorder therapy ravulizumab, a follow-up to Soliris which is already approved in the same indication.

Rivals rise as safety issue mars Pfizer’s DMD gene therapy trial

Rivals rise as safety issue mars Pfizer’s DMD gene therapy trial This involved an acute kidney injury, haemolysis, and reduced platelet count and required hospitalisation in intensive care, dialysis and treatment with Alexion’s kidney drug Soliris (eculizumab).

Alexion's Soliris adds new approval in rare disease NMOSD

Alexion's Soliris adds new approval in rare disease NMOSD First ever drug approved for rare autoimmune disease. Alexion has gained a new FDA approved used for its rare disease blockbuster Soliris. ... Soliris will nevertheless still face competition in the coming years from new challengers from the likes of

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...
OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...

Infographics